Categories

CEO Mark Capone talks about Myriad’s 25-year history and our pioneering work in the molecular diagnostics industry, as well as his vision for the future. “We’ve helped 2 million patients over the last 25 years, but we’re just getting started.”

Continue Reading

Six years ago, my doctor told me I had prostate cancer, and the news literally brought me to my knees. To say that I was scared at that moment is a big understatement. Nobody wants to hear the words, “You’ve got cancer,” and there are just no words to describe the devastation I felt. I…

Continue Reading

Our EVP of Human Resources Jayne Hart talks about why Myriad is such a special and unique place to work and how our passion for patients drives everything we do. “People want to make a difference and you can make that difference here at Myriad.”

Continue Reading

VP of Medical Services Susan Manley explains what genetic mutations are and how testing can definitively determine whether or not a cancer is hereditary in nature or is sporadically occurring. The results of genetic tests can empower people to take the necessary actions to reduce their risk for cancer.

Continue Reading

Dr. Johnathan Lancaster describes advances in the field of testing for hereditary endometrial and colon cancers, which are some of the most common cancers and are significant public health problems.

Continue Reading

VP of Medical Services Susan Manley talks about the emphasis Myriad places on test accuracy and the steps we take to make sure that all of our test results are as accurate and useful as possible.

Continue Reading


CEO Mark Capone talks about the primary challenges facing the molecular diagnostics industry and Myriad’s role as an industry leader in addressing these challenges.

Continue Reading

CEO Mark Capone describes Myriad’s efforts to ensure that patients have access to our tests because we understand how the tests can transform their lives. “That’s why we’ve put in place some of the leading financial assistance programs in the industry.”

Continue Reading

CEO Mark Capone explains what personalized medicine is and the role of genetics in tailoring and improving treatments for individual patients. “Historically, we would take a one-size-fits-all approach for all patients, but now, with personalized medicine, we can fundamentally change that approach.”

Continue Reading